James Sherblom - Net Worth and Insider Trading

James Sherblom Net Worth

The estimated net worth of James Sherblom is at least $13,228 dollars as of 2024-05-21. James Sherblom is the Director of Comera Life Sciences Holdings Inc and owns about 452,244 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $13,228. Details can be seen in James Sherblom's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Sherblom has not made any transactions after 2023-01-04 and currently still holds the listed stock(s).

Transaction Summary of James Sherblom

To

James Sherblom Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Sherblom owns 1 companies in total, including Comera Life Sciences Holdings Inc (CMRA) .

Click here to see the complete history of James Sherblom’s form 4 insider trades.

Insider Ownership Summary of James Sherblom

Ticker Comapny Transaction Date Type of Owner
CMRA Comera Life Sciences Holdings Inc 2023-01-04 director

James Sherblom Latest Holdings Summary

James Sherblom currently owns a total of 1 stock. James Sherblom owns 452,244 shares of Comera Life Sciences Holdings Inc (CMRA) as of January 4, 2023, with a value of $13,228.

Latest Holdings of James Sherblom

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CMRA Comera Life Sciences Holdings Inc 2023-01-04 452,244 0.03 13,228

Holding Weightings of James Sherblom


James Sherblom Form 4 Trading Tracker

According to the SEC Form 4 filings, James Sherblom has made a total of 2 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 81,081 shares on January 4, 2023, which cost James Sherblom around $99,730.

Insider Trading History of James Sherblom

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Sherblom Trading Performance

GuruFocus tracks the stock performance after each of James Sherblom's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Sherblom is -30.92%. GuruFocus also compares James Sherblom's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Sherblom within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Sherblom's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Sherblom

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.42
Relative Return to S&P 500(%) -5.61

James Sherblom Ownership Network

Ownership Network List of James Sherblom

No Data

Ownership Network Relation of James Sherblom


James Sherblom Owned Company Details

What does Comera Life Sciences Holdings Inc do?

Who are the key executives at Comera Life Sciences Holdings Inc?

James Sherblom is the director of Comera Life Sciences Holdings Inc. Other key executives at Comera Life Sciences Holdings Inc include Chief Financial Officer Michael Gerard Campbell , 10 percent owner Charles Cherington , and 10 percent owner David Soane .

Comera Life Sciences Holdings Inc (CMRA) Insider Trades Summary

Over the past 18 months, James Sherblom made 1 insider transaction in Comera Life Sciences Holdings Inc (CMRA) with a net purchase of 81,081. Other recent insider transactions involving Comera Life Sciences Holdings Inc (CMRA) include a net purchase of 3,677,227 shares made by Charles Cherington , a net purchase of 593,899 shares made by David Soane , and a net purchase of 33,783 shares made by Stuart A Randle .

In summary, during the past 3 months, insiders sold 0 shares of Comera Life Sciences Holdings Inc (CMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Comera Life Sciences Holdings Inc (CMRA) were sold and 4,467,508 shares were bought by its insiders, resulting in a net purchase of 4,467,508 shares.

Comera Life Sciences Holdings Inc (CMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Comera Life Sciences Holdings Inc Insider Transactions

No Available Data

James Sherblom Mailing Address

Above is the net worth, insider trading, and ownership report for James Sherblom. You might contact James Sherblom via mailing address: 12 Gill Street, Suite 4650, Woburn Ma 01801.

Discussions on James Sherblom

No discussions yet.